Cyclooxygenase inhibitory natural products: current status

Current Medicinal Chemistry
Sanjay M Jachak

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) are of huge therapeutic benefit in the treatment of rheumatoid arthritis and various types of inflammatory conditions. The target for these drugs is cyclooxygenase (COX), a rate-limiting enzyme involved in the conversion of arachidonic acid into inflammatory prostaglandins. COX-2 selective inhibitors are believed to have the same anti-inflammatory, anti-pyretic and analgesic activities as that of nonselective inhibitor NSAIDs with little or none of the gastrointestinal side effects. Thus, in the last 6-7 years several selective COX-2 inhibitors including coxibs were discovered and introduced into clinic. Recent reports evidence that selective COX-2 inhibitor such as rofecoxib, can lead to thrombotic cardiovascular events through inhibition of prostacyclin formation in the infracted heart. This has resulted in withdrawal of rofecoxib from the clinic in September 2004. Moreover, the COX-2/COX-1 selectivity ratio is vital in the design of COX-2 inhibitory drugs, as it is clear from rofecoxib, which is more than 50-fold COX-2 selective. After looking at all above mentioned facts, natural product-based compounds seem better as these compounds are generally supposed to be devoid of sever...Continue Reading

Citations

May 31, 2012·Archives of Pharmacal Research·Nagwa M Abd-El GawadRania M Abdelsalam
Nov 23, 2006·Neurosurgical Focus·Joseph C MaroonNathan A Ross
Jan 6, 2011·Surgical Neurology International·Joseph C MaroonAdara Maroon
Jul 18, 2015·Metabolites·Daniela A Chagas-PaulaRuAngelie Edrada-Ebel
Jun 8, 2013·Pharmacological Reports : PR·Phil-Dong MoonHyung-Min Kim
Oct 24, 2007·Journal of Ethnopharmacology·Hye-Jin JeonEun-Hee Park
Apr 21, 2009·Medicinal Research Reviews·Raju Gautam, Sanjay M Jachak
Nov 16, 2010·Journal of Ethnopharmacology·Weifeng LiLangchong He
Mar 6, 2012·Bioorganic & Medicinal Chemistry·Sai Kiran SharmaFrank Wuest
Jun 25, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Birgit WaltenbergerAtanas G Atanasov
Oct 21, 2016·ChemMedChem·Carlos F M SilvaArtur M S Silva
May 20, 2019·Journal of Cellular Biochemistry·Ajitha Gomathi, Kodiveri Muthukalianan Gothandam
Jul 1, 2011·Expert Opinion on Therapeutic Patents·Baker Jawabrah Al-HouraniFrank Wuest
Jan 12, 2013·The Physician and Sportsmedicine·Joseph C MaroonJeffrey W Bost
Jul 25, 2014·Experimental Biology and Medicine·Sung-Ho KimXue-Jiao Qian
Feb 11, 2015·Molecular and Cellular Biochemistry·Rajeshwari H PatilS Chidananda Sharma
Nov 7, 2017·Frontiers in Pharmacology·Ali AttiqKhairana Husain
Jan 28, 2020·Combinatorial Chemistry & High Throughput Screening·Malarvizhi RamalingamHannah R Vasanthi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.